Role of the Programmed Death-1 Pathway in Regulation of Alloimmune Responses In Vivo1

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Immunology

• Publication date

  2005-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.174.6.3408PMID 15749874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory T cells in transplantation tolerance.

  2005cited by this paper
• PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.

  2004cited by this paper
• New B7 Family Members with Positive and Negative Costimulatory Function

  2004cited by this paper
• The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.

  2004cited by this paper
• Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts

  2004cited by this paper
• Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

  2003cited by this paper
• Allograft Rejection in a New Allospecific CD4+ TCR Transgenic Mouse

  2003cited by this paper
• The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice

  2003cited by this paper
• Alternative T‐Cell Costimulatory Pathways in Transplant Rejection and Tolerance Induction: Hierarchy or Redundancy?

  2003cited by this paper
• Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production 1

  2003cited by this paper
• New TCR Transgenic Model for Tracking Allospecific CD4 T‐Cell Activation and Tolerance in Vivo

  2003cited by this paper
• Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses

  2003cited by this paper
• T‐cell costimulatory pathways in allograft rejection and tolerance

  2003cited by this paper
• Stimulating PD-1–negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival1

  2003cited by this paper
• Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis

  2003cited by this paper
• Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction

  2003cited by this paper
• Regulatory T cells in transplantation.

  2002cited by this paper
• Programmed Death-1 Targeting Can Promote Allograft Survival1

  2002cited by this paper
• Inability to Induce Tolerance Through Direct Antigen Presentation

  2002cited by this paper
• Expression of Programmed Death 1 Ligands by Murine T Cells and APC1

  2002cited by this paper
• Expression and Regulation of the PD‐L1 Immunoinhibitory Molecule on Microvascular Endothelial Cells

  2002cited by this paper
• Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size1

  2002cited by this paper
• PD‐1:PD‐L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL‐2

  2002cited by this paper
• Tracking the Immunoregulatory Mechanisms Active During Allograft Tolerance1

  2002cited by this paper
• Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

  2002influential reference
• Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.

  2002cited by this paper
• Programmed Death-1 Targeting Can Promote Allograft Survival

  2002cited by this paper
• Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

  2001cited by this paper
• B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function.

  2001cited by this paper
• Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1

  2001cited by this paper
• PD-1: an inhibitory immunoreceptor involved in peripheral tolerance.

  2001cited by this paper
• B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells

  2001cited by this paper
• CD4+CD25high Regulatory Cells in Human Peripheral Blood1

  2001cited by this paper
• Regulating the immune response to transplants. a role for CD4+ regulatory cells?

  2001cited by this paper
• Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.

  2001cited by this paper
• PD-L2 is a second ligand for PD-1 and inhibits T cell activation

  2001cited by this paper
• Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

  2001cited by this paper
• B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

  2000cited by this paper
• Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

  2000cited by this paper
• Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation

  2000cited by this paper
• Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4

  2000cited by this paper
• The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.

  1999cited by this paper
• Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

  1999cited by this paper
• Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

  1999cited by this paper
• CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.

  1999cited by this paper
• B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

  1999cited by this paper
• Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance

  1999cited by this paper
• Positive Selection Through a Motif in the αβ T Cell Receptor

  1998cited by this paper
• Positive selection through a motif in the alphabeta T cell receptor.

  1998cited by this paper
• The role of T-cell costimulatory activation pathways in transplant rejection.

  1998cited by this paper
• Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.

  1997cited by this paper
• Is CTLA-4 a master switch for peripheral T cell tolerance?

  1997cited by this paper
• The emerging role of CTLA-4 as an immune attenuator.

  1997cited by this paper
• Activation-induced expression of human programmed death-1 gene in T-lymphocytes.

  1997cited by this paper
• Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement.

  1996cited by this paper
• Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

  1996cited by this paper
• The Role of CTLA‐4 in the Regulation and Initiation of T‐Cell Responses

  1996cited by this paper
• Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

  1992cited by this paper
• T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection

  1989cited by this paper

• Trackable Tolerogenic Macrophages Integrate PD-L1 and Rapamycin Signaling to Suppress Alloimmune Responses in Transplantation.

  2026cites this paper
• Strategies to Overcome PD-1/PD-L1 Blockade Resistance: Focusing on Combination with Immune Checkpoint Blockades

  2025cites this paper
• Engineering hypoimmune stem cell-derived beta cells

  2025cites this paper
• Navigating the risks: a systematic review of immune checkpoint inhibitor therapy before liver transplant for hepatocellular carcinoma and its impact on allograft rejection and survival outcomes

  2025influential citation
• Programmed Death-Ligand 1 in Renal Allografts With Antibody-Mediated Rejection.

  2025cites this paper
• Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study.

  2025cites this paper
• Chronic Villitis as a Distinctive Feature of Placental Injury in Maternal SARS-CoV-2 Infection.

  2024cites this paper
• Immunotherapy and Transplantation for Hepatocellular Carcinoma.

  2024cites this paper
• Rethinking Immune Check Point Inhibitors Use in Liver Transplantation: Implications and Resistance

  2024cites this paper
• Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule.

  2024cites this paper
• Toxicity in the era of immune checkpoint inhibitor therapy

  2024cites this paper
• Fine-tuning tumor- and allo-immunity: advances in the use of immune checkpoint inhibitors in kidney transplant recipients

  2024cites this paper
• Signal pathways and precision therapy of small-cell lung cancer

  2022cites this paper
• Murine precursors to type 1 conventional dendritic cells induce tumor cytotoxicity and exhibit activated PD-1/PD-L1 pathway

  2022cites this paper
• Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro

  2021cites this paper
• Mesenchymal Stem Cell Mediated Immune Modulation Is Donor Sex Speci � c

  2021cites this paper
• The modulatory effect of Crotoxin and its Phospholipase A2 subunit from Crotalus durrissus terrificus venom on Dendritic Cells interfere with the generation of effector CD4+ T lymphocytes.

  2021cites this paper
• Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death

  2021influential citation
• Overexpression of PD-1 on T cells promotes tolerance in cardiac transplantation via ICOS-dependent mechanisms

  2021cites this paper
• Advances in Biological Function and Clinical Application of Small Extracellular Vesicle Membrane Proteins

  2021cites this paper
• Immunological Determinants of Liver Transplant Outcomes Uncovered by the Rat Model

  2021cites this paper
• Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes

  2020cites this paper
• The application of nano-medicine to overcome the challenges related to immune checkpoint blockades in cancer immunotherapy: Recent advances and opportunities.

  2020cites this paper
• Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression

  2020cites this paper
• IFN-γ Control of an Effector/Target Combination for Skin Allograft Rejection: Macrophage/Skin Components in Normal Mice or T Cell/Endothelial Cells in IFN-γ-Deficient Mice

  2020cites this paper
• Understanding, predicting and achieving liver transplant tolerance: from bench to bedside

  2020cites this paper
• Early T cell infiltration is modulated by programed cell death-1 protein and its ligand (PD-1/PD-L1) interactions in murine kidney transplants.

  2020cites this paper
• Multi-cellular and multi-molecular immune interactions in the transplantation tolerance and rejection

  2019cites this paper
• The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface

  2019cites this paper
• Meglumine acridone acetate, the ionic salt of CMA and N-methylglucamine, induces apoptosis in human PBMCs via the mitochondrial pathway

  2019cites this paper
• Correlation between MDSC and Immune Tolerance in Transplantation: Cytokines, Pathways and Cell-cell Interaction.

  2019cites this paper
• Pigs expressing the human inhibitory ligand PD‐L1 (CD 274) provide a new source of xenogeneic cells and tissues with low immunogenic properties

  2018cites this paper
• Immunothérapie dans le cancer bronchique non à petites cellules : étude rétrospective de l’utilisation des anti PD-1/PD-L1 au sein d’un Centre Régional de Lutte Contre le Cancer

  2018cites this paper
• Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer

  2018cites this paper
• B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine

  2018cites this paper
• Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells

  2018cites this paper
• IDO-expressing Fibroblasts Suppress the Development of Imiquimod-induced Psoriasis-like Dermatitis

  2018cites this paper
• Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.

  2018cites this paper
• CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis

  2018cites this paper
• Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?

  2018cites this paper
• PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?

  2017cites this paper
• PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients

  2017cites this paper
• Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics

  2017cites this paper
• Advances in targeting co‐inhibitory and co‐stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

  2017cites this paper
• PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice

  2016cites this paper
• DX 5 + CD 4 + T cells modulate CD 4 + T cell response via inhibition of IL-12 production by DCs Chapter 6 Hanane

  2016cites this paper
• Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation.

  2016cites this paper
• Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes

  2016cites this paper
• Porcine Islet-Specific Tolerance Induced by the Combination of Anti-LFA-1 and Anti-CD154 mAbs is Dependent on PD-1

  2016cites this paper
• Mouse models for studies of HLA-G functions in basic science and pre-clinical research.

  2016cites this paper
• NF-kB Regulation in T-cells in Pregnancy is Mediated via Fas/FasL Interactions: The Signal for which is Derived from Exosomes Present in Maternal Plasma

  2016cites this paper
• Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren’s syndrome in non-obese diabetic mice

  2016cites this paper
• T Cell Cosignaling Molecules in Transplantation.

  2016cites this paper
• Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.

  2016cites this paper
• Anti-inflammatory role of IDO and tryptophan metabolites

  2016cites this paper
• Inhibition of B‐cell activation and antibody production by triggering inhibitory signals via the PD‐1/PD‐ligand pathway

  2016cites this paper
• Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies

  2016cites this paper
• The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance

  2016cites this paper
• Acute GVHD results in a severe DC defect that prevents T-cell priming and leads to fulminant cytomegalovirus disease in mice.

  2015cites this paper
• Novel immunological strategies for islet transplantation.

  2015cites this paper
• Programmed Death-1 Controls T Cell Survival by Regulating Oxidative Metabolism

  2015cites this paper
• Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage.

  2015cites this paper
• The Role of Notch Receptors in the Alloimmune Response

  2015cites this paper
• Acute and Chronic Rejection: Compartmentalization and Kinetics Ff Counterbalancing Signals in Cardiac Transplants

  2015cites this paper
• Co-Inhibitory Pathways and Their Importance in Immune Regulation

  2014cites this paper
• T Helper Cells Fate Mapping by Co-stimulatory Molecules and its Functions in Allograft Rejection and Tolerance

  2014cites this paper
• Costimulatory Pathways in Kidney Transplantation: Pathogenetic Role, Clinical Significance and New Therapeutic Opportunities

  2014cites this paper
• Combining chemotherapy and checkpoint blockade in thoracic cancer: how to proceed?

  2014cites this paper
• Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4+ T cells tolerized by peptide immunotherapy

  2014influential citation
• An Agonistic Anti-BTLA mAb (3C10) Induced Generation of IL-10-Dependent Regulatory CD4+ T Cells and Prolongation of Murine Cardiac Allograft

  2014cites this paper
• Induction of PD-L1 on monocytes: a new mechanism by which IVIg inhibits mixed lymphocyte reactions.

  2014cites this paper
• Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.

  2014cites this paper
• FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS

  2014cites this paper
• Human Tolerance Maternal Acceptance of the Fetus: True

  2013cites this paper
• The immunomodulatory role of carbon monoxide during transplantation

  2013cites this paper
• Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.

  2013cites this paper
• Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells.

  2013cites this paper
• Costimulation blockade: current perspectives and implications for therapy.

  2013cites this paper
• T Cells to Transplanted Tissue + Peripheral Tolerance of Donor-reactive Cd8 Pd-1-dependent Mechanisms Maintain

  2013cites this paper
• Expresses Neither CD25 Nor Foxp3 Rat Model of Autoimmune Diabetes A Regulatory CD4+ T Cell Subset in the BB

  2013cites this paper
• T-cell co-stimulatory blockade in transplantation: two steps forward one step back!

  2013cites this paper
• DX5+CD4+ T cells modulate CD4+ T‐cell response via inhibition of IL‐12 production by DCs

  2013cites this paper
• Intact B7‐H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses

  2012cites this paper
• Anti-PD-1 and Anti-B7-H1/PD-L1 Monoclonal Antibodies

  2012cites this paper
• This information is current as via Programmed Death Ligand 1 Cells and Prolongs Islet Allograft Survival Mobilizes Autologous Hematopoietic Stem CXCL12 Axis - Targeting the CXCR4

  2012cites this paper
• Trogocytosis of CD80 and CD86 by induced regulatory T cells

  2012cites this paper
• Trophoblast debris modulates the expression of immune proteins in macrophages: a key to maternal tolerance of the fetal allograft?

  2012cites this paper
• IMMUNE MECHANISMS ASSOCIATED TO NEUROINFLAMMATION IN ALZHEIMER'S DISEASE

  2012cites this paper
• Role of the PD-1 Pathway in the Immune Response

  2012influential citation
• Effect of tolerogenic peptide administration on pathogenic antigen-experienced T cells

  2012cites this paper
• CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”

  2012cites this paper
• Astrocytes modulate microglial phenotype and dendritic cell-like properties

  2012cites this paper
• NKT cell self-reactivity: evolutionary master key of immune homeostasis?

  2012cites this paper
• Role of the PD‐1 Pathway in the Immune Response

  2012influential citation
• Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants.

  2012cites this paper
• The Role of Coinhibitory Signaling Pathways in Transplantation and Tolerance

  2012cites this paper
• Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation.

  2012cites this paper
• Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.

  2012cites this paper
• Anti–IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function

  2012cites this paper
• Antibodies Against B7-DC with Differential Binding Properties Exert Opposite Effects

  2012cites this paper